167 related articles for article (PubMed ID: 9758100)
21. Regulation of matrix metalloproteinases, tissue inhibitor of matrix metalloproteinase-1, and extracellular metalloproteinase inducer by interleukin-17 in human periodontal ligament fibroblasts.
Wu Y; Zhu L; Wei H; Peng B
J Endod; 2013 Jan; 39(1):62-7. PubMed ID: 23228259
[TBL] [Abstract][Full Text] [Related]
22. Proteolytic enzymes in equine joints with infectious arthritis.
Spiers S; May SA; Harrison LJ; Bennett D; Edwards GB
Equine Vet J; 1994 Jan; 26(1):48-50. PubMed ID: 8143664
[TBL] [Abstract][Full Text] [Related]
23. Zymographic analysis of latent and activated forms of matrix metalloproteinase-2 and -9 in synovial fluid: correlation to polymorphonuclear leukocyte infiltration and in response to infection.
Makowski GS; Ramsby ML
Clin Chim Acta; 2003 Mar; 329(1-2):77-81. PubMed ID: 12589968
[TBL] [Abstract][Full Text] [Related]
24. MMP-7 and TIMP-1, new targets in predicting poor wound healing in apical periodontitis.
Letra A; Ghaneh G; Zhao M; Ray H; Francisconi CF; Garlet GP; Silva RM
J Endod; 2013 Sep; 39(9):1141-6. PubMed ID: 23953287
[TBL] [Abstract][Full Text] [Related]
25. Autoactivation profiles of calcium-dependent matrix metalloproteinase-2 and -9 in inflammatory synovial fluid: effect of pyrophosphate and bisphosphonates.
Makowski GS; Ramsby ML
Clin Chim Acta; 2005 Aug; 358(1-2):182-91. PubMed ID: 15921672
[TBL] [Abstract][Full Text] [Related]
26. Measurement of cartilage oligomeric matrix protein (COMP) in normal and diseased equine synovial fluids.
Misumi K; Vilim V; Clegg PD; Thompson CC; Carter SD
Osteoarthritis Cartilage; 2001 Feb; 9(2):119-27. PubMed ID: 11237659
[TBL] [Abstract][Full Text] [Related]
27. Development of an enzyme-linked immunosorbent assay to measure total TIMP-1 (free TIMP-1 and TIMP-1 in combination with matrix-metalloproteinases) and measurement of TIMP 1 and CRP in serum.
Plumpton TA; Clark IM; Plumpton C; Calvin J; Cawston TE
Clin Chim Acta; 1995 Sep; 240(2):137-54. PubMed ID: 8548924
[TBL] [Abstract][Full Text] [Related]
28. Relationship of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover: analyses of synovial fluid from patients with osteoarthritis.
Ishiguro N; Ito T; Ito H; Iwata H; Jugessur H; Ionescu M; Poole AR
Arthritis Rheum; 1999 Jan; 42(1):129-36. PubMed ID: 9920023
[TBL] [Abstract][Full Text] [Related]
29. Rat pancreatic stellate cells secrete matrix metalloproteinases: implications for extracellular matrix turnover.
Phillips PA; McCarroll JA; Park S; Wu MJ; Pirola R; Korsten M; Wilson JS; Apte MV
Gut; 2003 Feb; 52(2):275-82. PubMed ID: 12524413
[TBL] [Abstract][Full Text] [Related]
30. Synthetic matrix metalloproteinase inhibitors and tissue inhibitor of metalloproteinase (TIMP)-2, but not TIMP-1, inhibit shedding of tumor necrosis factor-alpha receptors in a human colon adenocarcinoma (Colo 205) cell line.
Lombard MA; Wallace TL; Kubicek MF; Petzold GL; Mitchell MA; Hendges SK; Wilks JW
Cancer Res; 1998 Sep; 58(17):4001-7. PubMed ID: 9731514
[TBL] [Abstract][Full Text] [Related]
31. MMP-2, MMP-9, TIMP-1 and TIMP-2 levels in patients with rheumatoid arthritis and psoriatic arthritis.
Giannelli G; Erriquez R; Iannone F; Marinosci F; Lapadula G; Antonaci S
Clin Exp Rheumatol; 2004; 22(3):335-8. PubMed ID: 15144129
[TBL] [Abstract][Full Text] [Related]
32. Expression and functional properties of antibodies to tissue inhibitors of metalloproteinases (TIMPs) in rheumatoid arthritis.
Bokarewa M; Dahlberg L; Tarkowski A
Arthritis Res Ther; 2005; 7(5):R1014-22. PubMed ID: 16207317
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical study of matrix metalloproteinases-2 and -9, macrophage inflammatory protein-2 and tissue inhibitors of matrix metalloproteinases-1 and -2 in normal, purulonecrotic and fungal infected equine corneas.
Boveland SD; Moore PA; Mysore J; Krunkosky TM; Dietrich UM; Jarrett C; Paige Carmichael K
Vet Ophthalmol; 2010 Mar; 13(2):81-90. PubMed ID: 20447025
[TBL] [Abstract][Full Text] [Related]
34. [Regulation of matrix-degrading enzymes in gynecologic cancer tissues and cells].
Kikkawa F
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):618-22. PubMed ID: 8808829
[TBL] [Abstract][Full Text] [Related]
35. Metalloproteinases and their inhibitors are influenced by inhalative glucocorticoid therapy in combination with environmental dust reduction in equine recurrent airway obstruction.
Barton AK; Shety T; Bondzio A; Einspanier R; Gehlen H
BMC Vet Res; 2016 Dec; 12(1):282. PubMed ID: 27938355
[TBL] [Abstract][Full Text] [Related]
36. A study of metalloproteinases in fifty joint fluid specimens.
Gaudin P; Razakaboay M; Surla A; Berthier S; Fauconnier J; Morel F; Phelip X
Rev Rhum Engl Ed; 1997 Jun; 64(6):375-81. PubMed ID: 9513609
[TBL] [Abstract][Full Text] [Related]
37. Isolation and characterization of tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) from human rheumatoid synovial fluid.
Osthues A; Knäuper V; Oberhoff R; Reinke H; Tschesche H
FEBS Lett; 1992 Jan; 296(1):16-20. PubMed ID: 1730286
[TBL] [Abstract][Full Text] [Related]
38. Occurrence of matrix metalloproteinases and tissue inhibitors of metalloproteinases in tuberculous pleuritis.
Hoheisel G; Sack U; Hui DS; Huse K; Chan KS; Chan KK; Hartwig K; Schuster E; Scholz GH; Schauer J
Tuberculosis (Edinb); 2001; 81(3):203-9. PubMed ID: 11466032
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of tumor promoter activity toward mouse fibroblasts and their in vitro transformation by tissue inhibitor of metalloproteinases-1 (TIMP-1).
Shoji A; Sakamoto Y; Tsuchiya T; Moriyama K; Kaneko T; Okubo T; Umeda M; Miyazaki K
Carcinogenesis; 1997 Nov; 18(11):2093-100. PubMed ID: 9395207
[TBL] [Abstract][Full Text] [Related]
40. Control of extracellular matrix homeostasis of normal cartilage by a TGFbeta autocrine pathway. Validation of flow cytometry as a tool to study chondrocyte metabolism in vitro.
Wang L; Almqvist KF; Veys EM; Verbruggen G
Osteoarthritis Cartilage; 2002 Mar; 10(3):188-98. PubMed ID: 11869079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
